Erschienen in:
10.06.2020 | Comorbidities (T von Lueder & I Hopper, Section Editors)
Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction
verfasst von:
Andrew Xanthopoulos, Apostolos Dimos, Grigorios Giamouzis, Angeliki Bourazana, Alexandros Zagouras, Michail Papamichalis, Takeshi Kitai, John Skoularigis, Filippos Triposkiadis
Erschienen in:
Current Heart Failure Reports
|
Ausgabe 4/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
Heart failure (HF) patients often present with multiple coexisting morbidities. In this review, we contend that coexisting morbidities are highly prevalent and clinically important regardless of the left ventricular ejection fraction (LVEF).
Recent Findings
Multimorbidity is prevalent in the ambulatory subjects of the community and increases with age. Differences in the prevalence of coexisting morbidities between HF with preserved LVEF (> 50%), mid-range LVEF (40–50%), and reduced LVEF (< 40%) are either not demonstrable or whenever present are small and unrelated to morbidity and mortality. The constellation of coexisting morbidities together with the disease modifiers (age, sex, genes, other) defines the HF phenotype and outcome.
Summary
There is no robust evidence supporting an interaction in HF patients between the prevalence and clinical significance of coexisting morbidities and the LVEF.